PAPER Zeb A, Hameed A, Khan L, Khan I, Dalvandi K, Choudhary MI, Basha FZ
SEARCH RESULTS
331160 RESULTS
PAPER Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S
Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland.
J Clin Psychopharmacol. 2014 Aug;34(4):435-40. PubMed: 24875073PAPER Rivera-Escalera F, Matousek SB, Ghosh S, Olschowka JA, O'Banion MK
Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease.
Neurobiol Dis. 2014 Sep;69:124-33. Epub 2014 May 27 PubMed: 24874542PAPER Burbaeva GS, Boksha IS, Tereshkina EB, Starodubtseva LI, Savushkina OK, Vorob'eva EA, Prokhorova TA
[A role of glutamate decarboxylase in Alzheimer's disease].
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(4):68-72. PubMed: 24874321PAPER Marwarha G, Raza S, Meiers C, Ghribi O
Leptin attenuates BACE1 expression and amyloid-β genesis via the activation of SIRT1 signaling pathway.
Biochim Biophys Acta. 2014 Sep;1842(9):1587-95. Epub 2014 May 27 PubMed: 24874077PAPER Tariot PN
When should neuroprotective drugs move from mice to men?
Lancet Neurol. 2014 Jul;13(7):641-3. Epub 2014 May 27 PubMed: 24873721PAPER Stolley JM
Reaching Communities with Alzheimer's Education: Advanced Train-The-Trainer Manual.
J Gerontol Nurs. 2002 Jun 1;28(6):51. PubMed: 24869399PAPER Alagiakrishnan K, Zhao N, Mereu L, Senior PA, Senthilselvan A
Erratum to "Montreal Cognitive Assessment Is Superior to Standardized Mini-Mental Status Exam in Detecting Mild Cognitive Impairment in the Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus"
Biomed Res Int. 2014;2014:648472. Epub 2014 Apr 28 PubMed: 24877126PAPER Rabin LA, Chi SY, Wang C, Fogel J, Kann SJ, Aronov A
Prospective memory on a novel clinical task in older adults with mild cognitive impairment and subjective cognitive decline.
Neuropsychol Rehabil. 2014;24(6):868-93. Epub 2014 May 30 PubMed: 24875614PAPER Candela S, Giubilei F, Orzi F
Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism.
Arch Ital Biol. 2013 Dec;151(4):169-78. PubMed: 24873925PAPER Arosio B, D'Addario C, Gussago C, Casati M, Tedone E, Ferri E, Nicolini P, Rossi PD, Maccarrone M, Mari D
Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly.
Biomed Res Int. 2014;2014:169203. Epub 2014 Apr 30 PubMed: 24877062PAPER Fusco G, De Simone A, Gopinath T, Vostrikov V, Vendruscolo M, Dobson CM, Veglia G
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour.
Nat Commun. 2014 May 29;5:3827. PubMed: 24871041PAPER Maraganore DM
Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease.
J Mov Disord. 2011 May;4(1):1-7. Epub 2011 Apr 30 PubMed: 24868385PAPER Choi SA, Evidente VG, Caviness JN
Comparing Cerebral White Matter Lesion Burdens between Parkinson's Disease with and without Dementia.
J Mov Disord. 2010 May;3(1):6-10. Epub 2010 Apr 30 PubMed: 24868371PAPER Spencer D
Seizures and epileptiform activity in early Alzheimer disease: how hard should we be looking?
Epilepsy Curr. 2014 Mar;14(2):73-5. PubMed: 24872782Current Filters
No filters selected